Partners in progress: A conversation with Dr. Nathan Littlejohn on OncoEMR® for urology
The new frontier of academic research
.png)
A conversation with Dr. Ronac Mamtani on the evidence that moves oncology forward
Oncology trials: A new approach to improve accuracy and alleviate burden associated with patient identification
Flatiron’s Ingredient Drug Substitution for 505(b)(2) with Tennessee Oncology
.png)
Delivering person-centered cancer care: Top strategies for patient navigation
Five ways artificial intelligence is poised to revolutionize cancer care
